Article Information
History
- July 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jia Wei1,2,
- Philippa C. Matthews1,5,
- Nicole Stoesser1,3,4,5,
- Thomas Maddox6,
- Luke Lorenzi6,
- Ruth Studley6,
- John I Bell7,
- John N Newton8,
- Jeremy Farrar9,
- Ian Diamond6,
- Emma Rourke6,
- Alison Howarth1,5,
- Brian D. Marsden1,10,
- Sarah Hoosdally1,
- E Yvonne Jones1,
- David I Stuart1,
- Derrick W. Crook1,3,4,5,
- Tim E. A. Peto1,3,4,5,
- Koen B. Pouwels#,1,2,3,11,
- A. Sarah Walker#,1,2,3,12,
- David W. Eyre#,2,3,4,5,*,
- the COVID-19 Infection Survey team
- 1Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 2Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 3The National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK
- 4The National Institute for Health Research Oxford Biomedical Research Centre, University of Oxford, Oxford, UK
- 5Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
- 6Office for National Statistics, Newport, UK
- 7Office of the Regius Professor of Medicine, University of Oxford, Oxford, UK
- 8Health Improvement Directorate, Public Health England, London, UK
- 9Wellcome Trust, London, UK
- 10Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
- 11Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 12MRC Clinical Trials Unit at UCL, UCL, London, UK
- ↵*Corresponding author: Dr David Eyre, david.eyre{at}bdi.ox.ac.uk, +44 (0)1865 221081, Microbiology Department, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU
↵# contribution considered equal
Posted July 05, 2021.
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
